Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Deciphera Pharmaceuticals, Inc. (DCPH)  
$14.65 0.47 (3.31%) as of 4:30 Fri 4/26


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 60,930,000
Market Cap: 892.62(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $10.11 - $17.36
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Deciphera Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing medicines to improve the lives of people with cancer. QINLOCK, Co.'s switch-control kinase inhibitor, was developed using Co.'s proprietary drug discovery platform and developed for the treatment of fourth-line gastrointestinal stromal tumor. In addition, Co. has identified and developed various product candidates from its platform into clinical studies, including vimseltinib and DCC-3116. Co. is studying vimseltinib in a Phase 3 study in patients with tenosynovial giant cell tumor. DCC-3116 is designed to inhibit autophagy, a key tumor survival mechanism in cancer cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 21,000 3,166,644
Total Buy Value $0 $0 $291,244 $45,081,012
Total People Bought 0 0 2 3
Total Buy Transactions 0 0 2 4
Total Shares Sold 10,159 104,778 115,161 179,650
Total Sell Value $158,659 $1,458,255 $1,602,723 $2,646,007
Total People Sold 4 5 6 6
Total Sell Transactions 4 19 25 43
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 290
  Page 1 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Brightstar Associates Llc 10% Owner   –       –       •   2024-04-22 4 OE $0.01 $481 D/D 48,136 23,107,844     -
   Pitman Jama SVP, Chief Development Officer   •       –      –    2024-02-16 4 S $15.62 $35,405 D/D (2,267) 68,031 10%     
   Sherman Matthew L EVP & Chief Medical Officer   •       –      –    2024-02-16 4 S $15.62 $40,840 D/D (2,615) 108,739 10%     
   Martin Daniel C. Chief Commercial Officer   •       –      –    2024-02-16 4 S $15.62 $35,405 D/D (2,267) 55,118 10%     
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2024-02-16 4 S $15.62 $47,009 D/D (3,010) 80,350 10%     
   Pitman Jama SVP, Chief Development Officer   •       –      –    2024-02-15 4 A $0.00 $0 D/D 19,725 70,298     -
   Sherman Matthew L EVP & Chief Medical Officer   •       –      –    2024-02-15 4 A $0.00 $0 D/D 17,275 111,354     -
   Dhanak Dashyant EVP & Chief Scientific Officer   •       –      –    2024-02-15 4 A $0.00 $0 D/D 17,275 158,175     -
   Martin Daniel C. Chief Commercial Officer   •       –      –    2024-02-15 4 A $0.00 $0 D/D 9,725 57,385     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2024-02-15 4 A $0.00 $0 D/D 17,275 83,360     -
   Brightstar Associates Llc 10% Owner   –       –       •   2024-02-07 4 OE $0.01 $9,140 D/D 914,001 23,059,708     -
   Pitman Jama SVP, Chief Development Officer   •       –      –    2024-01-16 4 S $14.47 $23,499 D/D (1,624) 50,573 2%     
   Martin Daniel C. Chief Commercial Officer   •       –      –    2024-01-16 4 S $14.47 $23,499 D/D (1,624) 47,660 2%     
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2024-01-16 4 S $14.47 $35,234 D/D (2,435) 66,085 2%     
   Sherman Matthew L EVP & Chief Medical Officer   •       –      –    2024-01-16 4 S $14.47 $35,234 D/D (2,435) 94,079 2%     
   Sherman Matthew L EVP & Chief Medical Officer   •       –      –    2023-12-13 4 S $15.37 $42,905 D/D (2,792) 96,514 12%     
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2023-12-13 4 S $15.37 $42,905 D/D (2,792) 68,520 12%     
   Pitman Jama See Remarks   •       –      –    2023-12-13 4 S $15.37 $25,540 D/D (1,662) 52,197 12%     
   Martin Daniel C. Chief Commercial Officer   •       –      –    2023-12-13 4 S $15.37 $26,539 D/D (1,727) 49,284 12%     
   Hoerter Steven L. President and CEO   •       •      –    2023-12-13 4 S $15.37 $471,217 D/D (30,664) 72,763 12%     
   Sherman Matthew L EVP & Chief Medical Officer   •       –      –    2023-12-12 4 A $0.00 $0 D/D 8,244 99,306     -
   Kelly Thomas Patrick Chief Financial Officer   •       –      –    2023-12-12 4 A $0.00 $0 D/D 8,244 71,312     -
   Pitman Jama See Remarks   •       –      –    2023-12-12 4 A $0.00 $0 D/D 5,576 53,859     -
   Martin Daniel C. Chief Commercial Officer   •       –      –    2023-12-12 4 A $0.00 $0 D/D 5,576 51,011     -
   Hoerter Steven L. President and CEO   •       •      –    2023-12-12 4 A $0.00 $0 D/D 62,500 103,427     -
  290 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us